AFP and neoplasm: To address this, international risk classification standards were created based on the PRE-Treatment EXTent of tumor (PRETEXT) imaging staging system [2], serum Alpha-fetoprotein (AFP) values, and patient age to separate patients into very low-risk, low-risk, moderate-risk, and high-risk groups [3].